Monkeypox’s Spread Boosts Shares of Vaccine Manufacturer
- Bavarian’s smallpox vaccine is cleared in US for monkeypox
- Danish company has received one European order already
A laboratory at the Bavarian Nordic A/S, in Kvistgaard, Denmark.
Photographer: Freya Ingrid Morales/Bloomberg
This article is for subscribers only.
The spread of monkeypox boosted the shares of Bavarian Nordic A/S, which says it’s the only company to make a vaccine approved for the viral infection.
The Danish company gained as much as 26% in Copenhagen trading on Thursday after saying it had secured a contract to supply its smallpox shot -- which is also cleared against monkeypox -- to an undisclosed European country.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
Monkeypox’s Spread Boosts Shares of Vaccine Manufacturer